Product Details for ANDA 062279
GRIFULVIN V (GRISEOFULVIN, MICROCRYSTALLINE)
125MG
Marketing Status: Discontinued
250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
500MG
Marketing Status: Discontinued
125MG
Marketing Status: Discontinued
Active Ingredient: GRISEOFULVIN, MICROCRYSTALLINE
Proprietary Name: GRIFULVIN V
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 125MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062279
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: VALEANT PHARMACEUTICALS LUXEMBOURG SARL
Marketing Status: Discontinued
Patent and Exclusivity Information
GRIFULVIN V (GRISEOFULVIN, MICROCRYSTALLINE)
Proprietary Name: GRIFULVIN V
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 125MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062279
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: VALEANT PHARMACEUTICALS LUXEMBOURG SARL
Marketing Status: Discontinued
Patent and Exclusivity Information
250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: GRISEOFULVIN, MICROCRYSTALLINE
Proprietary Name: GRIFULVIN V
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062279
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: VALEANT PHARMACEUTICALS LUXEMBOURG SARL
Marketing Status: Discontinued
Patent and Exclusivity Information
GRIFULVIN V (GRISEOFULVIN, MICROSIZE)
Proprietary Name: GRIFULVIN V
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062279
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: VALEANT PHARMACEUTICALS LUXEMBOURG SARL
Marketing Status: Discontinued
Patent and Exclusivity Information
500MG
Marketing Status: Discontinued
Active Ingredient: GRISEOFULVIN, MICROSIZE
Proprietary Name: GRIFULVIN V
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062279
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: VALEANT PHARMACEUTICALS LUXEMBOURG SARL
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: GRIFULVIN V
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062279
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: VALEANT PHARMACEUTICALS LUXEMBOURG SARL
Marketing Status: Discontinued
Patent and Exclusivity Information